AGRX

Agile Therapeutics
AGRX

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

AGRX was delisted on the 25th of March, 2024.

Back to rankings

19 hedge funds and large institutions have $1.28M invested in Agile Therapeutics in 2022 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less funds holding

Funds holding: →

less funds holding in top 10

Funds holding in top 10: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

99% less capital invested

Capital invested by funds: $182M → $1.28M (-$181M)

Holders
19
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$125K
2
+$108K
3
+$67.3K
4
Two Sigma Investments
Two Sigma Investments
New York
+$53K
5
UBS Group
UBS Group
Switzerland
+$28.4K

Top Sellers

1
-$953K
2
-$460K
3
-$77.7K
4
State Street
State Street
Massachusetts
-$61K
5
FCBT
First Citizens Bank & Trust
North Carolina
-$42K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$620K
2
$143K
3
$108K
4
$103K
5
$68K
6
$56K
7
$53K
8
$35K
9
$30K
10
$22K
11
$20K
12
$20K
13
$2K
14
$1K
15
$1K
16
–
17
–
18
–
19
–
20
–
21
–
22
–
23
–
24
–
25
–
1
2